Inovio Pharmaceuticals, Inc. (NASDAQ:INO – Free Report) – Equities research analysts at HC Wainwright lowered their Q2 2024 earnings estimates for shares of Inovio Pharmaceuticals in a report released on Tuesday, May 14th. HC Wainwright analyst R. Selvaraju now forecasts that the biopharmaceutical company will post earnings of ($1.28) per share for the quarter, down […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was downgraded by research analysts at StockNews.com from a “hold” rating to a “sell” rating in a note issued to investors on Friday. A number of other research firms also recently weighed in on INO. JMP Securities started coverage on Inovio Pharmaceuticals in a report on Thursday, January […]
Inovio Pharmaceuticals (NASDAQ:INO – Get Free Report) was upgraded by StockNews.com from a “sell” rating to a “hold” rating in a report issued on Thursday. A number of other equities research analysts have also recently commented on the stock. Oppenheimer raised shares of Inovio Pharmaceuticals from a “market perform” rating to an “outperform” rating and […]
StockNews.com initiated coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 5.8 % INO stock opened at $0.38 on Friday. Inovio Pharmaceuticals has a one year low of $0.32 and a one […]
StockNews.com began coverage on shares of Inovio Pharmaceuticals (NASDAQ:INO – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Inovio Pharmaceuticals Trading Down 2.1 % NASDAQ:INO opened at $0.40 on Friday. The firm has a market capitalization of $109.58 million, a PE ratio of -0.64 […]